These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18176610)

  • 21. Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
    Tefferi A; Kumar S; Wolf RC; Lacy MQ; Inwards DJ; Gloor JM; Albright RC; Kamath PS; Litzow MR
    Bone Marrow Transplant; 2001 Nov; 28(10):997-9. PubMed ID: 11753559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.
    Wan CD; Cheng R; Wang HB; Liu T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
    Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?
    Khoury H; Adkins D; Brown R; Trinkaus K; Vij R; Miller G; Goodnough LT; DiPersio J
    Bone Marrow Transplant; 2000 Apr; 25(7):737-43. PubMed ID: 10745259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation.
    Schriber J; Milk B; Shaw D; Christiansen N; Baer M; Slack J; Tezcan H; Wetzler M; Herzig G
    Bone Marrow Transplant; 1999 Dec; 24(12):1311-4. PubMed ID: 10627640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease.
    Peres E; Kintzel P; Dansey R; Baynes R; Abidi M; Klein J; Ibrahim RB; Abella E
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):203-7. PubMed ID: 18388499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noise protection with N-acetyl-l-cysteine (NAC) using a variety of noise exposures, NAC doses, and routes of administration.
    Bielefeld EC; Kopke RD; Jackson RL; Coleman JK; Liu J; Henderson D
    Acta Otolaryngol; 2007 Sep; 127(9):914-9. PubMed ID: 17712668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy.
    Tolar J; Orchard PJ; Bjoraker KJ; Ziegler RS; Shapiro EG; Charnas L
    Bone Marrow Transplant; 2007 Feb; 39(4):211-5. PubMed ID: 17290278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm.
    Niemi TT; Munsterhjelm E; Pöyhiä R; Hynninen MS; Salmenperä MT
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):29-34. PubMed ID: 16607076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation.
    El-Serafi I; Remberger M; El-Serafi A; Benkessou F; Zheng W; Martell E; Ljungman P; Mattsson J; Hassan M
    Sci Rep; 2018 May; 8(1):8293. PubMed ID: 29844459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
    Najima Y; Ohashi K; Miyazawa M; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
    Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of activated charcoal administered more than four hours after acetaminophen overdose.
    Spiller HA; Winter ML; Klein-Schwartz W; Bangh SA
    J Emerg Med; 2006 Jan; 30(1):1-5. PubMed ID: 16434328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery.
    Köksal H; Rahman A; Burma O; Halifeoğlu I; Bayar MK
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):437-43. PubMed ID: 19103540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of hepatic veno-occlusive disease by a combination of heparin and prostaglandin E1 in children undergoing hematopoietic stem cell transplantation].
    Inukai T; Sugita K; Goi K; Akahane K; Hirose K; Nemoto A; Takahashi K; Sato H; Uno K; Furuichi Y; Nakamura M; Miyamoto N; Yamakawa N; Shiraishi K; Kojika S; Tezuka T; Iijima K; Nakazawa S
    Rinsho Ketsueki; 2004 Apr; 45(4):297-303. PubMed ID: 15168445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered metabolism of tacrolimus in hepatic veno-occlusive disease.
    Mori T; Shimizu T; Yamazaki R; Nakazato T; Ikeda Y; Okamoto S
    Transpl Int; 2005 Oct; 18(10):1215-7. PubMed ID: 16162110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy.
    Koneru B; Fisher A; He Y; Klein KM; Skurnick J; Wilson DJ; de la Torre AN; Merchant A; Arora R; Samanta AK
    Liver Transpl; 2005 Feb; 11(2):196-202. PubMed ID: 15666380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome.
    Al-Chalabi T; Underhill JA; Portmann BC; McFarlane IG; Heneghan MA
    Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1389-95; quiz 1287. PubMed ID: 18840547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
    Jang G; Ko OB; Kim S; Lee DH; Huh J; Suh C
    Transfusion; 2008 Apr; 48(4):640-6. PubMed ID: 18194384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fulminant liver failure due to severe veno-occlusive disease after haematopoietic cell transplantation: a depressing experience.
    MacQuillan GC; Mutimer D
    QJM; 2004 Sep; 97(9):581-9. PubMed ID: 15317927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity.
    Ibrahim RB; Peres E; Dansey R; Abidi MH; Abella EM; Klein J
    Ann Pharmacother; 2004 Jun; 38(6):1053-9. PubMed ID: 15113990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.